Drugmaker Eli Lilly and Co. says it’ll build a $3.5 billion manufacturing facility in Pennsylvania, as the company expands domestic production and capitalizes on surging sales of obesity and diabetes treatments

Leave a Reply

Your email address will not be published. Required fields are marked *